MedPath

The Neural Mechanisms of Imaginal Extinction

Not Applicable
Completed
Conditions
Fear of Spiders
Interventions
Behavioral: Threat conditioning
Behavioral: Imaginal extinction
Registration Number
NCT05168592
Lead Sponsor
Uppsala University
Brief Summary

Imaginal exposure is a widely used and effective psychological treatment technique in which patients are exposed to fearful stimuli and situations using mental imagery. This study examines imaginal extinction, an experimental analogue of imaginal exposure that allows the study of this treatment technique under controlled circumstances. During imaginal extinction, conditioned fear is diminished through repeated exposure to mental imagery of the feared (conditioned) stimulus. The neural underpinnings of imaginal extinction is not known, and hence, this study examines neural activations during imaginal extinction using psychophysiology and brain imaging.

Detailed Description

In this study, participants undergo threat conditioning to two pictures (CS+, CS-) in order to acquire a conditioned threat response. After this, the conditioned threat response is diminished through imaginal extinction (i.e extinction to the mental imagery of CS+ and CS-). Functional magnetic resonance imaging (7T) is used to measure neural activations during threat conditioning and imaginal extinction. Skin conductance is used to measure arousal response. Subjective fear and mental imagery vividness ratings will also be collected. In this way, this study aims to characterize the neural underpinnings of imaginal extinction.

Note that this study employs participants fearful of spiders. This is because data collection is shared with a related study (ClinicalTrials.gov ID 2020-06930a).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
87
Inclusion Criteria
  • Willing and able to provide informed consent and complete study procedures
  • Fear of spiders (due to data collection together with ID 2020-06930a)
Exclusion Criteria
  • Current psychiatric disorder other than spider phobia. Current use of psychotropic medication. Current neurological conditions. MRI-contraindications (i.e metal implants in skull).

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Imaginal extinctionThreat conditioningConditioned fear will be diminished using imaginal extinction.
Imaginal extinctionImaginal extinctionConditioned fear will be diminished using imaginal extinction.
Primary Outcome Measures
NameTimeMethod
Blood oxygen level dependent contrast (BOLD-signal) during threat conditioning and imaginal extinction.Day 1

BOLD-signal is assessed using functional magnetic resonance imaging.

Physiological arousal response during threat conditioning and imaginal extinction.Day 1

Skin conductance responses are used as a measure of physiological arousal response (i.e. event-related rise in electrodermal activity to stimuli).

Secondary Outcome Measures
NameTimeMethod
Task-specific mental imagery vividness during imaginal extinctionDay 1

Vividness of Imagery (scale:1-5; no image at all - image as clear and vivid as real life)

Vividness of visual imagery Questionnaire (VVIQ)One week after Day 1

VVIQ is used to measure individual differences in the Vividness of Visual mental Imagery; scale: 16-80 where higher scores represent a higher ability for visual imagery.

Ratings of subjective fear experienced during threat conditioning and imaginal extinction.Day 1

Scale 0-100; no fear at all - extreme fear

Spielberger State-Trait Anxiety Inventory (STAI-T)One week after Day 1

STAI-T is a self-rated questionnaire included assess trait-anxiety in the participants. Scale: 20-80, where higher scores represent higher levels of trait anxiety.

Trial Locations

Locations (1)

The Swedish 7T facility

πŸ‡ΈπŸ‡ͺ

Lund, Sweden

Β© Copyright 2025. All Rights Reserved by MedPath